These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 23580149
1. "Idiopathic Bence-Jones proteinuria": a new characterization of an old entity. Mian M, Franz I, Wasle I, Herold M, Griesmacher A, Prokop W, Cortelazzo S, Gastl G, Willenbacher W, Gunsilius E, Fiegl M. Ann Hematol; 2013 Sep; 92(9):1263-70. PubMed ID: 23580149 [Abstract] [Full Text] [Related]
2. "Idiopathic" Bence Jones proteinuria: long-term follow-up in seven patients. Kyle RA, Greipp PR. N Engl J Med; 1982 Mar 11; 306(10):564-7. PubMed ID: 7057813 [Abstract] [Full Text] [Related]
3. The clinical spectrum of pure Bence Jones proteinuria. A study of 66 patients. Pascali E, Pezzoli A. Cancer; 1988 Dec 01; 62(11):2408-15. PubMed ID: 3179959 [Abstract] [Full Text] [Related]
4. Idiopathic light-chain proteinuria: case report and review of the literature. Audard V, Damaj G, Rubio MT, Aucouturier P, Hermine O, Varet B. Am J Hematol; 2004 Jul 01; 76(3):293-4. PubMed ID: 15224371 [Abstract] [Full Text] [Related]
5. The outcome of idiopathic Bence Jones proteinuria. Kanoh T, Ohnaka T, Uchino H, Fujii H. Tohoku J Exp Med; 1987 Jan 01; 151(1):121-6. PubMed ID: 3107161 [Abstract] [Full Text] [Related]
6. [Current status regarding detection of monoclonal component in Japan]. Yamada T. Rinsho Byori; 2010 Apr 01; 58(4):397-400. PubMed ID: 20496769 [Abstract] [Full Text] [Related]
7. The urinary light-chain ladder pattern. A product of improved methodology that may complicate the recognition of Bence Jones proteinuria. Bailey EM, McDermott TJ, Bloch KJ. Arch Pathol Lab Med; 1993 Jul 01; 117(7):707-10. PubMed ID: 8323434 [Abstract] [Full Text] [Related]
11. [The significance of analysis and detection of Bence Jones protein in the urine in clinical laboratory diagnosis]. Végh Z, Ottó S. Orv Hetil; 1989 Aug 27; 130(35):1871-5. PubMed ID: 2507996 [Abstract] [Full Text] [Related]
14. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E. J Clin Oncol; 2002 Mar 15; 20(6):1625-34. PubMed ID: 11896113 [Abstract] [Full Text] [Related]
15. [A long-term observation of development from monoclonal gammopathy of undetermined significance (MGUS) into primary amyloidosis]. Kanoh T, Yago K, Okuma M. Rinsho Ketsueki; 1990 Oct 15; 31(10):1740-4. PubMed ID: 2255066 [Abstract] [Full Text] [Related]
18. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis. Stone MJ, Frendel EP. Am J Med; 1975 May 15; 58(5):601-19. PubMed ID: 1130419 [Abstract] [Full Text] [Related]